Literature DB >> 20544785

Orexin receptor antagonists: a new concept in CNS disorders?

John Gatfield1, Catherine Brisbare-Roch, Francois Jenck, Christoph Boss.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20544785     DOI: 10.1002/cmdc.201000132

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


× No keyword cloud information.
  19 in total

Review 1.  Chemistry and biology of multicomponent reactions.

Authors:  Alexander Dömling; Wei Wang; Kan Wang
Journal:  Chem Rev       Date:  2012-03-22       Impact factor: 60.622

Review 2.  Drug-induced sleep: theoretical and practical considerations.

Authors:  Jeffrey M Ellenbogen; Edward F Pace-Schott
Journal:  Pflugers Arch       Date:  2011-09-28       Impact factor: 3.657

3.  Effect of 1-substitution on tetrahydroisoquinolines as selective antagonists for the orexin-1 receptor.

Authors:  David A Perrey; Nadezhda A German; Ann M Decker; David Thorn; Jun-Xu Li; Brian P Gilmour; Brian F Thomas; Danni L Harris; Scott P Runyon; Yanan Zhang
Journal:  ACS Chem Neurosci       Date:  2015-02-12       Impact factor: 4.418

Review 4.  The hypocretin/orexin system: implications for drug reward and relapse.

Authors:  Ainhoa Plaza-Zabala; Rafael Maldonado; Fernando Berrendero
Journal:  Mol Neurobiol       Date:  2012-03-20       Impact factor: 5.590

5.  Synthesis and Evaluation of Orexin-1 Receptor Antagonists with Improved Solubility and CNS Permeability.

Authors:  David A Perrey; Ann M Decker; Yanan Zhang
Journal:  ACS Chem Neurosci       Date:  2017-11-20       Impact factor: 4.418

6.  Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats.

Authors:  Alessandra Matzeu; Rémi Martin-Fardon
Journal:  Neuropharmacology       Date:  2019-12-04       Impact factor: 5.250

Review 7.  Possible Role of CRF-Hcrt Interaction in the Infralimbic Cortex in the Emergence and Maintenance of Compulsive Alcohol-Seeking Behavior.

Authors:  Jung S Kim; Rémi Martin-Fardon
Journal:  Alcohol Clin Exp Res       Date:  2020-01-02       Impact factor: 3.455

Review 8.  Therapeutics development for addiction: Orexin-1 receptor antagonists.

Authors:  David A Perrey; Yanan Zhang
Journal:  Brain Res       Date:  2018-08-24       Impact factor: 3.252

Review 9.  G proteins, p60TRP, and neurodegenerative diseases.

Authors:  Klaus Heese
Journal:  Mol Neurobiol       Date:  2013-01-24       Impact factor: 5.590

10.  The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor.

Authors:  David A Perrey; Ann M Decker; Jun-Xu Li; Brian P Gilmour; Brian F Thomas; Danni L Harris; Scott P Runyon; Yanan Zhang
Journal:  Bioorg Med Chem       Date:  2015-07-16       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.